Posted by Michael Wonder on 17 Mar 2022
Health Canada authorises Moderna's COVID-19 vaccine in children (6-11 years)
17 March 2022 - Announcement follows recent authorisation of the Company's mRNA COVID-19 vaccine in Australia and the European Union for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in children aged 6-11 years.
Moderna today announced that Health Canada has approved the use of Moderna's mRNA COVID-19 vaccine, Spikevax, in a two dose series of 50 µg per dose for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in children aged 6 to11 years.
